Based on the Cellink AB (publ) stock forecast from 0 analysts, the average analyst target price for Cellink AB (publ) is not available over the next 12 months. Cellink AB (publ)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Cellink AB (publ) is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Cellink AB (publ)’s stock price was EUR 2.77. Cellink AB (publ)’s stock price has changed by -9.31% over the past week, -23.17% over the past month and -50.04% over the last year.
No recent analyst target price found for Cellink AB (publ)
No recent average analyst rating found for Cellink AB (publ)
Company Overview Cellink AB (publ)
BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end products and services in precision dispensing, advanced sample preparation, multiplex analysis and assay miniaturization, diagnostic and medical device manufacturing for life science and diagnostic industries. It primarily serves medical, pharmaceutical, and cosmetic industries. The company offers its products through sales organizations, as well as through an extensive distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden. Read Less
BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferati...Read More
Frequently Asked Questions About Cellink AB (publ) (49Z:F) Stock
Stock Target Advisor's fundamental analysis for Cellink AB (publ)'s stock is Slightly Bearish.
Unfortunately we do not have enough data on 49Z:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 49Z:F's stock to indicate what its average analyst target is.
49Z:F stock's Price/Earning ratio is 83.40.
Our analysis grades 49Z:F stock's Price / Earning ratio at F. This means that 49Z:F stock's Price/Earning ratio is above 79% of the stocks in the Medical Devices sector in the F exchange.
Based on this 49Z:F may be a overvalued for its sector.
The last closing price of 49Z:F's stock was EUR 2.77.
The most recent market capitalization for 49Z:F is EUR 0.19B.
Unfortunately we do not have enough analyst data on 49Z:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Cellink AB (publ)'s stock.
As per our most recent records Cellink AB (publ) has 832 Employees.
Cellink AB (publ)'s registered address is LAngfilsgatan 9, Gothenburg, Sweden, 412 77.
You can get more information about it from Cellink AB (publ)'s website at https://www.bico.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Cellink AB (publ) (49Z:F) Stock
Stock Target Advisor's fundamental analysis for Cellink AB (publ)'s stock is Slightly Bearish.
Unfortunately we do not have enough data on 49Z:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 49Z:F's stock to indicate what its average analyst target is.
49Z:F stock's Price/Earning ratio is 83.40.
Our analysis grades 49Z:F stock's Price / Earning ratio at F. This means that 49Z:F stock's Price/Earning ratio is above 79% of the stocks in the Medical Devices sector in the F exchange.
Based on this 49Z:F may be a overvalued for its sector.
The last closing price of 49Z:F's stock was EUR 2.77.
The most recent market capitalization for 49Z:F is EUR 0.19B.
Unfortunately we do not have enough analyst data on 49Z:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Cellink AB (publ)'s stock.
As per our most recent records Cellink AB (publ) has 832 Employees.
Cellink AB (publ)'s registered address is LAngfilsgatan 9, Gothenburg, Sweden, 412 77.
You can get more information about it from Cellink AB (publ)'s website at https://www.bico.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 49Z:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
